What Cardima does

Cardima — operating as 四川锦江电子医疗器械科技股份有限公司 (Sichuan Jinjiang Electronics Medical Device Technology Co., Ltd.) and headquartered in Chengdu, China — is a privately held cardiac electrophysiology (EP) medical device company founded in 2003. It designs, manufactures, and sells minimally invasive, single-use catheter-based systems for the diagnosis and treatment of cardiac arrhythmias (atrial fibrillation, ventricular tachycardia, paroxysmal supraventricular tachycardia, atrial flutter). In 2011, the company acquired CARDIMA, Inc., the former US NASDAQ-listed EP device manufacturer (CADME:OB), absorbing its Pathfinder, Revelation, VUEPORT/NAVIPORT, and INTELLITEMP product lines and gaining an international technology footprint.

The company's core technology spans three integrated platforms. First, the LEAD-Mapping® 3D cardiac EP mapping and navigation system, built on proprietary magnetic-electric dual-localization technology with sub-millimeter repositioning accuracy (≤1mm) and adaptive electric-field 3D positioning, gained NMPA approval in December 2022. Second, the LEAD-PFA® pulsed field ablation system, claimed as the world's first magnetic-navigation PFA system integrating 3D modeling, mapping, and ablation, with sub-millisecond (0.3 ms) non-thermal tissue-selective pulses that avoid pulmonary vein stenosis, esophageal injury, and phrenic nerve damage. Third, the legacy 3Ding® system, which in 2013 became China's first domestically developed cardiac 3D mapping platform (CFDA-approved). The broader portfolio includes VATION® RF ablation generators (100C, 100C Pro, HL series), NAVABLATOR® saline-irrigated RF catheters, VUEPORT® transseptal access needles and sheaths, PROMAPPER® magnetic-positioning diagnostic catheters (STAR, HELIX NAV, NAV), SynNuo® electrophysiology stimulators, LEAD-EP® multi-channel recorders, and pain-management and vascular-intervention devices.

Cardima monetizes through hardware and disposable-consumable sales to hospitals and cardiology departments via a nationwide direct field-sales force supported by clinical engineering staff, complemented by a regional distributor channel and academic-conference-driven KOL engagement. Pricing follows the Chinese hospital public-tender/bidding model. Strategic investment from Shenzhen-listed Xilitai Pharmaceutical (002294.SZ) was secured in January 2018, alongside a 2014 Suzhou Industrial Park joint venture for manufacturing capacity. The company has accumulated numerous invention patents, multiple NMPA approvals, CE certification (2015), the National IP Advantage Enterprise recognition (2022), and the National Specialized and Sophisticated 'Little Giant' Enterprise designation from MIIT (November 2025).

Name

Cardima

Legal name

四川锦江电子医疗器械科技股份有限公司

Website

https://cardima.com

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

11–50 employees

Short description

Cardima (Sichuan Jinjiang Electronics Medical Device Technology) is a Chengdu, China-based cardiac electrophysiology medical device company that designs, manufactures, and sells pulsed field ablation systems, 3D mapping platforms, RF ablation generators, and proprietary magnetic-positioning disposable catheters to hospitals and cardiology departments across China.

Ownership category

akta.pro rank

Product category

Cardiac Electrophysiology Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Electrophysiology Mapping & Ablation Systems (HLAHAFAD)

Keywords

• Cardiac electrophysiology devices
• Pulsed field ablation systems
• Cardiac 3D mapping systems
• Radiofrequency ablation catheters
• Electrophysiology diagnostic catheters

Headquarters

HQ city

Fremont

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

1. 高端医疗器械研发、生产和销售: 公司长期深耕心脏电生理领域，致力于高端创新诊断、消融医疗器械的研发、生产和销售，产品涵盖三维标测系统、脉冲电场消融系统、射频消融系统及相关耗材导管
2. 诊断类设备和耗材: 多道生理记录仪、电生理标测导管、刺激仪等诊断类产品，包括LEAD-EP多道生理记录仪、PROMAPPER系列标测导管、SynNuo电生理刺激仪等
3. 消融类设备和耗材: 脉冲电场消融仪、射频消融仪及配套消融导管，包括LEAD-PFA心脏脉冲电场消融仪、NAVABLATOR射频消融导管等一次性使用耗材

Go-to-market motion3 records

Distribution channels3 records

Marketing channels5 records

Core offering

Cardima designs, develops, manufactures, and markets minimally invasive cardiac electrophysiology (EP) medical devices for diagnosing and treating cardiac arrhythmias. Its portfolio spans 3D cardiac mapping systems, pulsed field ablation (PFA) systems, radiofrequency (RF) ablation generators and catheters, electrophysiology diagnostic catheters, multi-channel physiological recorders, and transseptal access devices used by hospitals performing interventional cardiology procedures.

Product overview

Cardima (四川锦江电子医疗器械科技股份有限公司) operates as a cardiac electrophysiology (EP) medical device company offering a comprehensive portfolio of diagnostic, mapping, ablation, and access products for the treatment of cardiac arrhythmias. The product portfolio is organized around three main platforms: (1) the LEAD-PFA® pulsed field ablation (PFA) platform comprising the LEAD-PFA® generator and PulsedFA® disposable PFA catheters including the second-generation PulsedFA®FocalPoint with magnetic positioning and pressure monitoring; (2) the LEAD-Mapping® cardiac electrophysiology 3D mapping and navigation platform, a next-generation magnetic-electric dual positioning system that integrates with magnetic positioning catheters (PROMAPPER® STAR, HELIX NAV, NAV, fixed-bend, and adjustable-bend variants), reference electrodes (LEAD-REF6), and ablation systems; and (3) the legacy 3Ding® 3D mapping system (first domestically-made Chinese system, 2013). The RF ablation portfolio includes VATION®-100C/100C Pro and HL-75F/100F series radiofrequency generators, NAVABLATOR® and NAVABLATOR® COOL NAV saline-irrigated RF catheters, and VATION®-DeepCool/CoolPump perfusion pumps. Access products include the VUEPORT® transseptal puncture needles and adjustable-bend introducer sheath sets, with magnetic positioning variants (VUEPORT® NAV). Diagnostic instruments span multi-channel physiological recorders (LEAD-EP®, LEAD-7000/9000 series), the SynNuo® electrophysiology stimulator, and the LEAD®-PTCA EP recording system. Pain management and vascular intervention products round out the portfolio. In 2011, Cardima acquired US-listed CARDIMA, Inc., bringing internationally领先的 Pathfinder micro-catheters, Revelation multi-electrode RF catheters, and VUEPORT/NAVIPORT guide catheters into its portfolio.

Differentiator

Problem solved

Functional benefit

Products and services

• LEAD-PFA® Cardiac Pulse Field Ablation Generator Pulsed field ablation (PFA) generator used with disposable PFA ablation catheters for treating drug-refractory recurrent symptomatic paroxysmal atrial fibrillation (PAF). It is the company's flagship PFA platform, integrating 3D modeling, mapping, and ablation in one system.
• PulsedFA® FocalPoint Disposable Magnetic Positioning Pressure-Monitoring PFA Catheter Second-generation magnetic positioning pressure-monitoring pulsed field ablation catheter for treatment of paroxysmal supraventricular tachycardia (PSVT). Provides real-time catheter position information and contact pressure feedback when used with the LEAD-Mapping® system.
• PulsedFA® Disposable Cardiac PFA Ablation Catheter Disposable pulsed field ablation catheter for treatment of drug-refractory recurrent symptomatic paroxysmal atrial fibrillation. Works with LEAD-PFA® generator and LEAD-Mapping® system for 3D mapping, stimulation, and catheter position tracking.
• LEAD-Mapping® Cardiac EP 3D Mapping System Flagship cardiac electrophysiology 3D mapping and navigation platform using magnetic-electric dual positioning technology. Performs cardiac electrophysiological mapping and 3D modeling, displays catheter position, and measures cardiac and vascular pressure during EP procedures.
• PROMAPPER® STAR Disposable Magnetic Positioning Star-Shaped Mapping Catheter Magnetic positioning star-shaped mapping catheter for intracardiac electrophysiological mapping, recording, and stimulation. Provides catheter position information within the heart when used with the LEAD-Mapping® system.
• PROMAPPER® HELIX NAV Disposable Magnetic Positioning Circular Mapping Catheter Magnetic positioning circular (loop) mapping catheter for electrophysiological mapping, stimulation, and catheter position information when used with the LEAD-Mapping® system and disposable body surface reference electrode.
• PROMAPPER® NAV Disposable Magnetic Positioning Adjustable-Bend Mapping Catheter Magnetic positioning adjustable-bend mapping catheter for intracardiac electrophysiological mapping, recording, and stimulation with catheter position tracking when used with the LEAD-Mapping® system.
• SynNuo® Electrophysiology Stimulator Electrophysiological stimulation instrument providing electrical stimulation during cardiac EP diagnosis for refractory period measurement, rapid arrhythmia induction and termination, and electrical conduction measurement.
• LEAD-EP® Multi-Channel Physiological Recorder Multi-channel physiological recorder for recording body surface ECG, intracardiac ECG waveforms, measuring cardiac and vascular pressure, and delivering stimulation during clinical diagnosis or electrophysiological research.
• 3Ding® Cardiac Electrophysiology 3D Mapping System First domestically-developed Chinese cardiac 3D mapping system using digital frequency synthesis, digital demodulation, and digital processing for precise, stable, and safe 3D electric field positioning. Supports catheter 3D spatial positioning, 3D cardiac chamber anatomical geometry modeling, endocardial and surface ECG recording, activation time and propagation mapping.
• VATION®-100C Pro Cardiac RF Ablation Generator Advanced cardiac radiofrequency ablation generator used with disposable RF ablation catheters or magnetic positioning saline-irrigated RF ablation catheters for treatment of paroxysmal supraventricular tachycardia.
• NAVABLATOR® COOL NAV Disposable Magnetic Positioning Saline-Irrigated RF Ablation Catheter Magnetic positioning saline-irrigated radiofrequency ablation catheter for intracardiac ablation procedures. Provides real-time position information when used with VATION®-100C cardiac RF ablation generator and LEAD-Mapping® 3D mapping system; indicated for paroxysmal supraventricular tachycardia.
• VUEPORT® Transseptal Puncture Needle Transseptal puncture needle for creating atrial septal puncture to introduce intracardiac electrophysiology catheters into the left heart, used with a transseptal sheath.
• VATION®-DeepCool Perfusion Pump Perfusion pump for delivering physiological saline to irrigated ablation catheters during cardiac ablation procedures, reducing ablation electrode temperature.
• LEAD®-PTCA Electrophysiology Recording System Electrophysiology recording system for recording body surface ECG, measuring cardiac and vascular pressure, pulse oximetry, and non-invasive blood pressure in adults for clinical diagnosis.
• CARDIMA Pathfinder / Pathfinder Mini Series EP Diagnostic Micro-Catheters (Acquired Brand Line) Electrophysiological diagnostic micro-catheters for atrial fibrillation and ventricular tachycardia diagnosis and treatment. Acquired from US-based CARDIMA, Inc. as part of the 2011 acquisition and integrated into the company's EP diagnostic catheter portfolio.
• CARDIMA Revelation Series Multi-Electrode Cardiac RF Ablation Catheters (Acquired Brand Line) Linear-wound multi-electrode cardiac radiofrequency ablation catheter series for treating atrial fibrillation and ventricular tachycardia. Acquired from US-based CARDIMA, Inc. in 2011.

Quantifiable outcome

• 3Ding心脏三维标测系统重定位精度≤1mm
• +3 more outcomes

Named customers2 records

Segments1 record

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Two partnerships are on record, tiered minor and core.

• 苏州信迈医疗器械有限责任公司minorStrategic or Co-development Partner · 1 January 20142014年在苏州工业园区成立合资公司——苏州信迈医疗器械有限责任公司，作为公司战略布局的重要组成部分。
• CARDIMA, Inc. (美国)coreOEM/ Whitelabel/ Licensing Partner · 18 February 20112011年2月成功收购美国纳斯达克上市的高科技医疗器械公司CARDIMA, Inc.。CARDIMA公司是一家专业设计、研发、生产、销售心房纤颤、室性心动过速等心律失常诊断与治疗产品的医疗设备制造商，主要产品包括Pathfinder系列电生理诊断微型导管、Revelation系列心脏射频消融导管、VUEPORT和NAVIPORT系列导引导管等，在同类产品中处于国际领先水平。

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• HeartFlow: Although a broader cardiovascular diagnostics player, HeartFlow operates as a broader incumbent in cardiac imaging and is only weakly adjacent; included as a broader incumbent benchmark rather than a direct EP peer.

Direct peers

• Medtronic: Sells the CardioInsight mapping system and a broad portfolio of ablation catheters (including Affera/Prism), positioning it as a direct global rival to Cardima in cardiac EP mapping and ablation.
• Boston Scientific: Markets the Rhythmia mapping system and a deep RF/PFA ablation catheter portfolio (Farapulse/Farawave acquired), competing directly with Cardima's LEAD-Mapping and LEAD-PFA systems.
• Abbott: Operates the EnSite X 3D mapping system and TactiCath/Sensor Enabled ablation catheters in EP; a leading global competitor to Cardima across the full cardiac EP workflow.
• APT Medical (惠泰医疗): Leading Chinese electrophysiology interventional device manufacturer (Shenzhen-listed) that develops mapping and ablation catheters — a domestic equivalent directly competing with Cardima for Chinese EP hospital contracts.
• Johnson & Johnson (Biosense Webster): Global market leader in cardiac electrophysiology with the CARTO 3D mapping system and a broad ablation catheter portfolio (including nascent PFA); directly competes with Cardima in EP mapping and ablation technology for arrhythmia treatment.

Emerging players

• Stereotaxis: US-listed developer of magnetic-navigation robotic EP systems (Niobe/Genesis); competes in the magnetic-navigation EP niche Cardima's LEAD-PFA also targets.
• Acutus Medical: Developed AcQMap 3D mapping and PFA catheters for atrial fibrillation; an emerging global peer whose PFA roadmap competes with Cardima's LEAD-PFA in the next-generation ablation segment.
• MicroPort EP (Shanghai MicroPort EP Medtech): Chinese EP-focused subsidiary/affiliate developing 3D mapping (Columbus) and ablation catheters; emerging domestic peer whose roadmap overlaps closely with Cardima's magnetic-positioning EP platform.

Regional players

• Jonton (康龙化成 / 锦江电子 affiliates): Unable to identify a verifiable peer company by this name in cardiac EP; please disregard.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries2 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cardima